Call for Posters – CHI’s 2nd Annual FAST: Functional Analysis & Screening Technologies Congress

NEEDHAM, Mass. - Aug. 27, 2014 - PRLog -- Deadline for submission is October 10, 2014.

CHI welcomes posters on these topics:

* 3D cellular models and technologies for drug and target screening
* Successfully applying phenotypic screens in drug discovery
* Phenotypic drug discovery
* Body-on-a-chip systems for toxicological evaluations
* Organotypic culture models (OCMs) for each organ-specific testing regime, such as kidney,  heart, liver and gut
* Factors that are important for a successful phenotypic screening strategy
* 3D cellular models and technologies for drug and target screening
* Phenotypic screening in physiologically-relevant models
* Developing biodynamic screening assays for 3D live-tissue models
* An all-human microphysiologic liver system for carcinoma metastasis
* Discovering unexpected phenotypes using image-based profiling
* Merging advanced biomaterials and microscale technologies to create 3D vascularized tissues
* 2D versus 3D culture models: when to make the switch

Poster presenters will be published in the conference proceedings and will be entered into a drawing to win a cash prize.

To secure a poster board and inclusion in the conference materials, your abstract must be submitted, approved and your registration paid in full by October 10, 2014.

For submission details, visit http://www.fastcongress.com/fast_content.aspx?id=125056

For questions, please contact Jamie Ring, 781-972-5403, jring@healthtech.com.

About Cambridge Healthtech Institute (chicorporate.com)

Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation.